financetom
Business
financetom
/
Business
/
Abbott Laboratories Recalling HeartMate 3 Left Ventricular Assist System Implant Kit
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Abbott Laboratories Recalling HeartMate 3 Left Ventricular Assist System Implant Kit
May 15, 2024 8:07 AM

10:41 AM EDT, 05/15/2024 (MT Newswires) -- Abbott Laboratories ( ABT ) is recalling its HeartMate 3 Left Ventricular Assist System Implant Kit due to risk of blood leakage or air entering between inflow cannula and apical cuff, the US Food and Drug Administration said Wednesday.

The recall covers 882 devices in the US distributed from March 1, 2021, to present, the FDA said. The implant kit assists the heart in pumping blood when it cannot do so effectively on its own.

Abbott has reported 81 incidents related to this issue, which include 70 injuries and two deaths, according to the FDA.

Price: 104.43, Change: +0.42, Percent Change: +0.40

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
IonQ, Department of Energy Plan Quantum Technologies in Space
IonQ, Department of Energy Plan Quantum Technologies in Space
Sep 17, 2025
04:40 PM EDT, 09/17/2025 (MT Newswires) -- IonQ ( IONQ ) said late Wednesday that it has signed a memorandum of understanding with the US Department of Energy to develop quantum technologies in space. The collaboration would show quantum networking and secure communications via Capella Space, expanding US quantum space capabilities, the company said. IonQ ( IONQ ) said it...
Blackstone and TPG revive interest in buying Hologic, source says
Blackstone and TPG revive interest in buying Hologic, source says
Sep 17, 2025
(Reuters) -Private equity firms Blackstone and TPG revived their interest in acquiring medical device maker Hologic, a person close to the transaction said on Wednesday. This follows a Bloomberg News report from May saying that Hologic had declined a $16 billion non-binding offer from the private equity firms. ...
United Therapeutics Insider Sold Shares Worth $1,601,062, According to a Recent SEC Filing
United Therapeutics Insider Sold Shares Worth $1,601,062, According to a Recent SEC Filing
Sep 17, 2025
04:38 PM EDT, 09/17/2025 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on September 16, 2025, sold 4,000 shares in United Therapeutics ( UTHR ) for $1,601,062. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 644,489 common shares of the company, with 130 shares held directly and 644,359 controlled indirectly. SEC...
Liquidia Insider Sold Shares Worth $1,174,974, According to a Recent SEC Filing
Liquidia Insider Sold Shares Worth $1,174,974, According to a Recent SEC Filing
Sep 17, 2025
04:43 PM EDT, 09/17/2025 (MT Newswires) -- Raman Singh, Director, on September 15, 2025, sold 45,524 shares in Liquidia ( LQDA ) for $1,174,974. Following the Form 4 filing with the SEC, Singh has control over a total of 31,255 common shares of the company, with 31,255 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1819576/000110465925090852/xslF345X05/tm2526264-1_4seq1.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved